Derk Amsen (Sanquin) received a Dutch Cancer Society (KWF) grant in the category ‘Unique High-risk projects’ for his project: ‘Improvement of adoptive cancer T-cell therapies requires in vivo testing’
Amsterdam institute for Immunology and Infectious diseases
![](/upload_mm/6/9/3/cid16810_derk%20poging%202-oie_2091251XcmIG2Lr%20%282%29_756x324_215x162.jpg)
April 19, 2021